Numab
Numab is a biotech company in Horgen, Switzerland, founded in 2011. It has raised $165.0M across 2 rounds, most recently a $55.0M Extension Round in January 2025.
Numab Therapeutics AG
- Headquarters
- Horgen
- Employees
- 51–200
- Founded
- 2011
- Business Model
- B2B
- Website
- numab.com
- Total Funding
- $165.0M
- Last Round
- $55.0M Extension RoundJan 2025
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.
About
Numab Therapeutics AG is a clinical-stage Swiss biotech that designs multi-specific antibody medicines with proprietary λ-Cap and MATCH platforms. Its plug-and-play therapeutic design process is meant to overcome historical drug-discovery barriers and yield first-in-class and best-in-class treatments for patients with chronic inflammation and cancer. Numab collaborates with partners such as Boehringer Ingelheim on multi-specific antibodies and advanced pipeline candidate NM26, an anti-IL4R/IL-31 antibody acquired by Johnson & Johnson in 2024.
Summary
It lists 51–200 employees. It has raised $165.0M in total across 2 rounds, most recently a $55.0M Extension Round in Jan 2025. Investors include Novo Holdings A/S, HBM Partners and Forbion Capital Partners.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2025
Sign up to see all 2 events
Funding: Series C through Extension Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/numab"><img src="https://indexed.vc/api/badge/company/numab" alt="Numab on Indexed.vc" width="260" height="76" /></a>